FDA inspection
Bostal Drug Delivery Co., Ltd.: FDA inspection ending Aug 25, 2023
FDA inspection 1217731 · Voluntary Action Indicated (VAI) · Guangzhou
Key facts
| Inspection ID | 1217731 |
|---|---|
| Firm | Bostal Drug Delivery Co., Ltd. |
| FEI number | 3003548131 |
| Address | Ruixiang Road Facility, No. 228 Ruixiang Road; Guangzhou Jingjikaifa Huangpu |
| City | Guangzhou |
| Fiscal year | 2023 |
| Inspection end date | Aug 25, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data